Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANKS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SRGAP2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CNRIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKCI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RMST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEG10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC643923 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SERPINB13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCUN1D4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYTL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBPJL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01351 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EFNA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on